RNA Avidity Biosciences | $44.74 +9.0% | 9/10/2025 | | Reiterated Rating | $75.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 9/10/2025 |
TRML Tourmaline Bio | $47.61 +0.0% | 9/10/2025 | | Downgrade | $70.00 ➝ $48.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 9/10/2025 |
RGNX REGENXBIO | $9.20 -3.1% | 9/8/2025 | | Reiterated Rating | $52.00 | Buy | 00.00% | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 9/8/2025 |
QURE uniQure | $16.49 -2.7% | 9/8/2025 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 9/8/2025 |
CLSK Cleanspark | $10.35 +1.5% | 9/8/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 9/8/2025 |
VFS VinFast Auto | $3.28 +0.3% | 9/5/2025 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 9/5/2025 |
QURE uniQure | $16.49 -2.7% | 8/29/2025 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/29/2025 |
OTLK Oncobiologics | $1.04 -4.6% | 8/28/2025 | | Reiterated Rating | $3.00 | Neutral | 00.00% | View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 8/28/2025 |
PRTA Prothena | $8.21 -2.6% | 8/28/2025 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 8/28/2025 |
KRYS Krystal Biotech | $143.68 -0.5% | 8/22/2025 | | Lower Price Target | $219.00 ➝ $216.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/22/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 8/20/2025 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/20/2025 |
LXEO Lexeo Therapeutics | $5.18
| 8/15/2025 | | Lower Price Target | $20.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 8/15/2025 |
MGX Metagenomi | $1.86 -1.6% | 8/15/2025 | | Lower Price Target | $12.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 8/15/2025 |
PVLA Palvella Therapeutics | $56.84 -2.8% | 8/15/2025 | | Boost Price Target | $50.00 ➝ $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 8/15/2025 |
MGTX MeiraGTx | $7.61 -0.8% | 8/15/2025 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/15/2025 |
OTLK Oncobiologics | $1.04 -4.6% | 8/15/2025 | | Reiterated Rating | $3.00 | Neutral | 00.00% | View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 8/15/2025 |
ZURA Zura Bio | $2.00 -1.0% | 8/15/2025 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/15/2025 |
FBRX Forte Biosciences | $10.56 +1.0% | 8/15/2025 | | Reiterated Rating | $61.00 | Buy | 00.00% | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 8/15/2025 |
IMRX Immuneering | $8.49 +3.4% | 8/14/2025 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/14/2025 |
TRML Tourmaline Bio | $47.61 +0.0% | 8/14/2025 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 8/14/2025 |
SLDB Solid Biosciences | $5.39 +1.5% | 8/14/2025 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 8/14/2025 |
VFS VinFast Auto | $3.28 +0.3% | 8/14/2025 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 8/14/2025 |
OBIO Orchestra BioMed | $2.57 -1.9% | 8/13/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/13/2025 |
MNPR Monopar Therapeutics | $49.22 +3.3% | 8/13/2025 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Monopar Therapeutics (NASDAQ:MNPR) on 8/13/2025 |
KRRO Korro Bio | $30.76 -10.6% | 8/13/2025 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Korro Bio (NASDAQ:KRRO) on 8/13/2025 |
STOK Stoke Therapeutics | $23.46 -1.8% | 8/13/2025 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 8/13/2025 |
ADVM Adverum Biotechnologies | $3.02 -3.8% | 8/13/2025 | | Reiterated Rating | $33.00 | Buy | 00.00% | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/13/2025 |
COYA Coya Therapeutics | $6.05 -2.6% | 8/13/2025 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/13/2025 |
TSHA Taysha Gene Therapies | $3.07 -5.2% | 8/12/2025 | | Boost Price Target | $9.00 ➝ $10.00 | Buy | 00.00% | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/12/2025 |
CNTA Centessa Pharmaceuticals | $21.81 -3.8% | 8/12/2025 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 8/12/2025 |
XENE Xenon Pharmaceuticals | $36.21 -2.7% | 8/12/2025 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for Chardan Capital rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/12/2025 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 8/12/2025 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/12/2025 |
DIS Walt Disney | $116.02 -0.9% | 8/11/2025 | | Reiterated Rating | | Buy | 00.00% | View details for Chardan Capital rating of Walt Disney (NYSE:DIS) on 8/11/2025 |
ABUS Arbutus Biopharma | $4.46 -9.0% | 8/11/2025 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/11/2025 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 8/11/2025 | | Lower Price Target | $12.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2025 |
NTLA Intellia Therapeutics | $11.42
| 8/11/2025 | | Lower Price Target | $68.00 ➝ $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/11/2025 |
ARWR Arrowhead Pharmaceuticals | $29.72
| 8/11/2025 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/11/2025 |
CRVO CervoMed | $8.85 -3.8% | 8/11/2025 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 8/11/2025 |
SNTI Senti Biosciences | $1.35 -2.2% | 8/8/2025 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 8/8/2025 |
PRME Prime Medicine | $4.07 -0.2% | 8/8/2025 | | Lower Price Target | $12.00 ➝ $10.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 8/8/2025 |
|
RNA Avidity Biosciences | $44.74 +9.0% | 8/8/2025 | | Reiterated Rating | $75.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/8/2025 |
IOVA Iovance Biotherapeutics | $2.27 -6.2% | 8/8/2025 | | Lower Price Target | $25.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/8/2025 |
PRQR ProQR Therapeutics | $2.19
| 8/8/2025 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/8/2025 |
CLSK Cleanspark | $10.35 +1.5% | 8/8/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 8/8/2025 |
SLN Silence Therapeutics | $4.51 -7.6% | 8/8/2025 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/8/2025 |
SABS SAB Biotherapeutics | $2.12
| 8/8/2025 | | Lower Price Target | $20.00 ➝ $12.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 8/8/2025 |
CGTX Cognition Therapeutics | $2.17 -8.1% | 8/8/2025 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 8/8/2025 |
RGNX REGENXBIO | $9.20 -3.1% | 8/8/2025 | | Reiterated Rating | $52.00 | Buy | 00.00% | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/8/2025 |
TNYA Tenaya Therapeutics | $1.20 -6.3% | 8/7/2025 | | Reiterated Rating | $9.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/7/2025 |
EYPT Eyepoint Pharmaceuticals | $13.35 +0.2% | 8/7/2025 | | Reiterated Rating | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/7/2025 |
OBIO Orchestra BioMed | $2.57 -1.9% | 8/7/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/7/2025 |
CRSP CRISPR Therapeutics | $56.26 +0.7% | 8/5/2025 | | Reiterated Rating | $82.00 | Buy | 00.00% | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/5/2025 |
KRYS Krystal Biotech | $143.68 -0.5% | 8/5/2025 | | Reiterated Rating | $219.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/5/2025 |
PRTA Prothena | $8.21 -2.6% | 8/5/2025 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 8/5/2025 |
OCGN Ocugen | $1.07
| 8/4/2025 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 8/4/2025 |
ALNY Alnylam Pharmaceuticals | $465.89 -0.6% | 8/1/2025 | | Boost Price Target | $325.00 ➝ $400.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/1/2025 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 8/1/2025 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/1/2025 |
MNMD Mind Medicine (MindMed) | $9.44 -2.2% | 8/1/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 8/1/2025 |
CNTA Centessa Pharmaceuticals | $21.81 -3.8% | 7/30/2025 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 7/30/2025 |
QURE uniQure | $16.49 -2.7% | 7/29/2025 | | Lower Price Target | $38.00 ➝ $35.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/29/2025 |
DYN Dyne Therapeutics | $13.15 -0.2% | 7/29/2025 | | Lower Price Target | $50.00 ➝ $38.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 7/29/2025 |
PRAX Praxis Precision Medicines | $37.71 -4.3% | 7/29/2025 | | Reiterated Rating | $80.00 | Buy | 00.00% | View details for Chardan Capital rating of Praxis Precision Medicines (NASDAQ:PRAX) on 7/29/2025 |
KRYS Krystal Biotech | $143.68 -0.5% | 7/25/2025 | | Reiterated Rating | $219.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 7/25/2025 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 7/24/2025 | | Lower Price Target | $17.00 ➝ $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 7/24/2025 |
IOVA Iovance Biotherapeutics | $2.27 -6.2% | 7/23/2025 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 7/23/2025 |
CLSD Clearside Biomedical | $0.32 -8.6% | 7/18/2025 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 7/18/2025 |
CLSK Cleanspark | $10.35 +1.5% | 7/8/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/8/2025 |
VFS VinFast Auto | $3.28 +0.3% | 7/7/2025 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 7/7/2025 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 7/3/2025 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/3/2025 |
COYA Coya Therapeutics | $6.05 -2.6% | 7/1/2025 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 7/1/2025 |
CRSP CRISPR Therapeutics | $56.26 +0.7% | 6/26/2025 | | Reiterated Rating | $82.00 | Buy | 00.00% | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 6/26/2025 |
IBIO iBio | $0.93 -3.1% | 6/25/2025 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NYSE:IBIO) on 6/25/2025 |
CLSK Cleanspark | $10.35 +1.5% | 6/25/2025 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 6/25/2025 |
PASG Passage Bio | $7.00 +0.4% | 6/24/2025 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 6/24/2025 |
FBRX Forte Biosciences | $10.56 +1.0% | 6/24/2025 | | Reiterated Rating | $61.00 | Buy | 00.00% | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 6/24/2025 |
OCGN Ocugen | $1.07
| 6/24/2025 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 6/24/2025 |
VFS VinFast Auto | $3.28 +0.3% | 6/23/2025 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 6/23/2025 |
MNPR Monopar Therapeutics | $49.22 +3.3% | 6/23/2025 | | Initiated Coverage | $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Monopar Therapeutics (NASDAQ:MNPR) on 6/23/2025 |
IMRX Immuneering | $8.49 +3.4% | 6/18/2025 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 6/18/2025 |
DYN Dyne Therapeutics | $13.15 -0.2% | 6/17/2025 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 6/17/2025 |
SLN Silence Therapeutics | $4.51 -7.6% | 6/13/2025 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 6/13/2025 |
SNTI Senti Biosciences | $1.35 -2.2% | 6/12/2025 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 6/12/2025 |
VFS VinFast Auto | $3.28 +0.3% | 6/10/2025 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 6/10/2025 |
RNA Avidity Biosciences | $44.74 +9.0% | 6/9/2025 | | Boost Price Target | $65.00 ➝ $75.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 6/9/2025 |
RGNX REGENXBIO | $9.20 -3.1% | 6/9/2025 | | Reiterated Rating | $52.00 | Buy | 00.00% | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 6/9/2025 |
QURE uniQure | $16.49 -2.7% | 5/30/2025 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/30/2025 |
WBX Wallbox | $4.03 -3.1% | 5/28/2025 | | Upgrade | | Hold | 00.00% | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 5/28/2025 |
TSHA Taysha Gene Therapies | $3.07 -5.2% | 5/29/2025 | | Boost Price Target | $7.00 ➝ $9.00 | Buy | 00.00% | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/29/2025 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 5/28/2025 | | Lower Price Target | $46.00 ➝ $17.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/28/2025 |
PRTA Prothena | $8.21 -2.6% | 5/27/2025 | | Lower Price Target | $40.00 ➝ $18.00 | Buy | 00.00% | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 5/27/2025 |
|
DRUG Bright Minds Biosciences | $48.75 -1.3% | 5/21/2025 | | Reiterated Rating | $80.00 ➝ $80.00 | Buy | 00.00% | View details for Chardan Capital rating of Bright Minds Biosciences (NASDAQ:DRUG) on 5/21/2025 |
CLSK Cleanspark | $10.35 +1.5% | 5/21/2025 | | Initiated Coverage | $26.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 5/21/2025 |
PRME Prime Medicine | $4.07 -0.2% | 5/19/2025 | | Lower Price Target | $16.00 ➝ $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 5/19/2025 |
SLDB Solid Biosciences | $5.39 +1.5% | 5/19/2025 | | Lower Price Target | $16.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 5/19/2025 |
IPSC Century Therapeutics | $0.50 -3.4% | 5/16/2025 | | Lower Price Target | $7.00 ➝ $6.00 | Buy | 00.00% | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 5/16/2025 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 5/16/2025 | | Boost Price Target | $45.00 ➝ $46.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/16/2025 |
SABS SAB Biotherapeutics | $2.12
| 5/15/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/15/2025 |
ADVM Adverum Biotechnologies | $3.02 -3.8% | 5/15/2025 | | Reiterated Rating | $33.00 ➝ $33.00 | Buy | 00.00% | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 5/15/2025 |
MGX Metagenomi | $1.86 -1.6% | 5/15/2025 | | Lower Price Target | $13.00 ➝ $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 5/15/2025 |
MGTX MeiraGTx | $7.61 -0.8% | 5/14/2025 | | Lower Price Target | $38.00 ➝ $35.00 | Buy | 00.00% | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 5/14/2025 |
COYA Coya Therapeutics | $6.05 -2.6% | 5/13/2025 | | Reiterated Rating | $14.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/13/2025 |
KRRO Korro Bio | $30.76 -10.6% | 5/13/2025 | | Reiterated Rating | $25.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Korro Bio (NASDAQ:KRRO) on 5/13/2025 |
OBIO Orchestra BioMed | $2.57 -1.9% | 5/13/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 5/13/2025 |
LXEO Lexeo Therapeutics | $5.18
| 5/13/2025 | | Lower Price Target | $22.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 5/13/2025 |
ARWR Arrowhead Pharmaceuticals | $29.72
| 5/13/2025 | | Reiterated Rating | $60.00 ➝ $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/13/2025 |
XENE Xenon Pharmaceuticals | $36.21 -2.7% | 5/13/2025 | | Reiterated Rating | $55.00 ➝ $55.00 | Buy | 00.00% | View details for Chardan Capital rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 5/13/2025 |
CRVO CervoMed | $8.85 -3.8% | 5/12/2025 | | Boost Price Target | $14.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 5/12/2025 |
QURE uniQure | $16.49 -2.7% | 5/12/2025 | | Reiterated Rating | $38.00 ➝ $38.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/12/2025 |
OCGN Ocugen | $1.07
| 5/12/2025 | | Reiterated Rating | $7.00 ➝ $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/12/2025 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 5/9/2025 | | Lower Price Target | $28.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 5/9/2025 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 5/9/2025 | | Lower Price Target | $54.00 ➝ $45.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/9/2025 |
IOVA Iovance Biotherapeutics | $2.27 -6.2% | 5/9/2025 | | Lower Price Target | $30.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/9/2025 |
OCS Oculis | $17.40 +1.0% | 5/9/2025 | | Boost Price Target | $28.00 ➝ $33.00 | Buy | 00.00% | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 5/9/2025 |
SLN Silence Therapeutics | $4.51 -7.6% | 5/9/2025 | | Lower Price Target | $55.00 ➝ $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 5/9/2025 |
DYN Dyne Therapeutics | $13.15 -0.2% | 5/9/2025 | | Reiterated Rating | $50.00 ➝ $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/9/2025 |
PRTA Prothena | $8.21 -2.6% | 5/9/2025 | | Reiterated Rating | $40.00 ➝ $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 5/9/2025 |
TNYA Tenaya Therapeutics | $1.20 -6.3% | 5/9/2025 | | Reiterated Rating | $9.00 ➝ $9.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 5/9/2025 |
NTLA Intellia Therapeutics | $11.42
| 5/9/2025 | | Reiterated Rating | $68.00 ➝ $68.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/9/2025 |
MNMD Mind Medicine (MindMed) | $9.44 -2.2% | 5/9/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/9/2025 |
EYPT Eyepoint Pharmaceuticals | $13.35 +0.2% | 5/8/2025 | | Lower Price Target | $33.00 ➝ $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 5/8/2025 |
CGTX Cognition Therapeutics | $2.17 -8.1% | 5/8/2025 | | Lower Price Target | $8.00 ➝ $4.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 5/8/2025 |
MCRB Seres Therapeutics | $15.91 -9.4% | 5/8/2025 | | Reiterated Rating | $1.25 ➝ $6.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2025 |
CNTA Centessa Pharmaceuticals | $21.81 -3.8% | 5/8/2025 | | Initiated Coverage | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 5/8/2025 |
DRUG Bright Minds Biosciences | $48.75 -1.3% | 5/7/2025 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Chardan Capital rating of Bright Minds Biosciences (NASDAQ:DRUG) on 5/7/2025 |
PRAX Praxis Precision Medicines | $37.71 -4.3% | 5/7/2025 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Chardan Capital rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/7/2025 |
CRSP CRISPR Therapeutics | $56.26 +0.7% | 5/7/2025 | | Lower Price Target | $84.00 ➝ $82.00 | Buy | 00.00% | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/7/2025 |
XENE Xenon Pharmaceuticals | $36.21 -2.7% | 5/7/2025 | | Initiated Coverage | $55.00 | Buy | 00.00% | View details for Chardan Capital rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 5/7/2025 |
RNA Avidity Biosciences | $44.74 +9.0% | 5/7/2025 | | Reiterated Rating | $65.00 ➝ $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/7/2025 |
KRYS Krystal Biotech | $143.68 -0.5% | 5/7/2025 | | Reiterated Rating | $219.00 ➝ $219.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 5/7/2025 |
IMRX Immuneering | $8.49 +3.4% | 5/6/2025 | | Reiterated Rating | $13.00 ➝ $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 5/6/2025 |
QURE uniQure | $16.49 -2.7% | 5/6/2025 | | Reiterated Rating | $38.00 ➝ $38.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/6/2025 |
IBIO iBio | $0.93 -3.1% | 5/5/2025 | | Reiterated Rating | $5.00 ➝ $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NYSE:IBIO) on 5/5/2025 |
TRML Tourmaline Bio | $47.61 +0.0% | 5/5/2025 | | Reiterated Rating | $70.00 ➝ $70.00 | Buy | 00.00% | View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 5/5/2025 |
SNTI Senti Biosciences | $1.35 -2.2% | 5/2/2025 | | Reiterated Rating | $12.00 ➝ $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 5/2/2025 |
ALNY Alnylam Pharmaceuticals | $465.89 -0.6% | 5/2/2025 | | Boost Price Target | $300.00 ➝ $325.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/2/2025 |
WBX Wallbox | $4.03 -3.1% | 4/29/2025 | | Upgrade | | Hold | 00.00% | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 4/29/2025 |
VFS VinFast Auto | $3.28 +0.3% | 4/29/2025 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/29/2025 |
CLSK Cleanspark | $10.35 +1.5% | 4/29/2025 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 4/29/2025 |
COYA Coya Therapeutics | $6.05 -2.6% | 4/28/2025 | | Reiterated Rating | $14.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/28/2025 |
VFS VinFast Auto | $3.28 +0.3% | 4/28/2025 | | Reiterated Rating | $13.00 ➝ $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/28/2025 |
|
TRML Tourmaline Bio | $47.61 +0.0% | 4/23/2025 | | Initiated Coverage | $70.00 | Buy | 00.00% | View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 4/23/2025 |
OBIO Orchestra BioMed | $2.57 -1.9% | 4/22/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 4/22/2025 |
OCS Oculis | $17.40 +1.0% | 4/17/2025 | | Reiterated Rating | $28.00 ➝ $28.00 | Buy | 00.00% | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 4/17/2025 |
ADVM Adverum Biotechnologies | $3.02 -3.8% | 4/17/2025 | | Lower Price Target | $40.00 ➝ $33.00 | Buy | 00.00% | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/17/2025 |
KRRO Korro Bio | $30.76 -10.6% | 4/16/2025 | | Initiated Coverage | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Korro Bio (NASDAQ:KRRO) on 4/16/2025 |
PVLA Palvella Therapeutics | $56.84 -2.8% | 4/9/2025 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 4/9/2025 |
LXEO Lexeo Therapeutics | $5.18
| 4/8/2025 | | Lower Price Target | $25.00 ➝ $22.00 | Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 4/8/2025 |
SONN Sonnet BioTherapeutics | $5.90 +49.0% | 4/7/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Sonnet BioTherapeutics (NASDAQ:SONN) on 4/7/2025 |
OBIO Orchestra BioMed | $2.57 -1.9% | 4/1/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 4/1/2025 |
FBRX Forte Biosciences | $10.56 +1.0% | 4/1/2025 | | Lower Price Target | $64.00 ➝ $61.00 | Buy | 00.00% | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 4/1/2025 |
SABS SAB Biotherapeutics | $2.12
| 4/1/2025 | | Lower Price Target | $25.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/1/2025 |
QURE uniQure | $16.49 -2.7% | 4/1/2025 | | Initiated Coverage | $27.00 ➝ $38.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 4/1/2025 |
CLSD Clearside Biomedical | $0.32 -8.6% | 3/28/2025 | | Reiterated Rating | $90.00 ➝ $90.00 | Buy | 00.00% | View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 3/28/2025 |
SONN Sonnet BioTherapeutics | $5.90 +49.0% | 3/28/2025 | | Reiterated Rating | $20.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Sonnet BioTherapeutics (NASDAQ:SONN) on 3/28/2025 |
ABUS Arbutus Biopharma | $4.46 -9.0% | 3/28/2025 | | Reiterated Rating | $5.00 ➝ $5.00 | Buy | 00.00% | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/28/2025 |
GANX Gain Therapeutics | $1.66 -3.5% | 3/28/2025 | | Reiterated Rating | $6.00 ➝ $6.00 | Buy | 00.00% | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/28/2025 |
ALUR Allurion Technologies | $2.17 -1.1% | 3/27/2025 | | Reiterated Rating | $2.50 ➝ $2.50 | Neutral | 00.00% | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 3/27/2025 |
ZURA Zura Bio | $2.00 -1.0% | 3/26/2025 | | Lower Price Target | $12.00 ➝ $10.00 | Buy | 00.00% | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
WBX Wallbox | $4.03 -3.1% | 3/24/2025 | | Upgrade | | Hold | 00.00% | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 3/24/2025 |
VFS VinFast Auto | $3.28 +0.3% | 3/24/2025 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 3/24/2025 |
CLSK Cleanspark | $10.35 +1.5% | 3/24/2025 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 3/24/2025 |
LXEO Lexeo Therapeutics | $5.18
| 3/25/2025 | | Reiterated Rating | $25.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 3/25/2025 |
IMRX Immuneering | $8.49 +3.4% | 3/24/2025 | | Reiterated Rating | $13.00 ➝ $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/24/2025 |
IPSC Century Therapeutics | $0.50 -3.4% | 3/24/2025 | | Lower Price Target | $11.00 ➝ $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 3/24/2025 |
ALNY Alnylam Pharmaceuticals | $465.89 -0.6% | 3/21/2025 | | Reiterated Rating | $300.00 ➝ $300.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/21/2025 |
ALUR Allurion Technologies | $2.17 -1.1% | 3/21/2025 | | Reiterated Rating | $2.50 | Neutral | 00.00% | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 3/21/2025 |
CGTX Cognition Therapeutics | $2.17 -8.1% | 3/21/2025 | | Lower Price Target | $11.00 ➝ $8.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/21/2025 |
MCRB Seres Therapeutics | $15.91 -9.4% | 3/20/2025 | | Reiterated Rating | $25.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/20/2025 |
RGNX REGENXBIO | $9.20 -3.1% | 3/20/2025 | | Reiterated Rating | $52.00 ➝ $52.00 | Buy | 00.00% | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/20/2025 |
PRME Prime Medicine | $4.07 -0.2% | 3/20/2025 | | Boost Price Target | $15.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 3/20/2025 |
COYA Coya Therapeutics | $6.05 -2.6% | 3/20/2025 | | Reiterated Rating | $14.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2025 |
STOK Stoke Therapeutics | $23.46 -1.8% | 3/19/2025 | | Reiterated Rating | $24.00 ➝ $24.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 3/19/2025 |
RNA Avidity Biosciences | $44.74 +9.0% | 3/17/2025 | | Reiterated Rating | $65.00 ➝ $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/17/2025 |
DYN Dyne Therapeutics | $13.15 -0.2% | 3/17/2025 | | Reiterated Rating | $50.00 ➝ $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/17/2025 |
PRQR ProQR Therapeutics | $2.19
| 3/14/2025 | | Reiterated Rating | $4.00 ➝ $4.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2025 |
RGNX REGENXBIO | $9.20 -3.1% | 3/14/2025 | | Reiterated Rating | $52.00 ➝ $52.00 | Buy | 00.00% | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/14/2025 |
OCS Oculis | $17.40 +1.0% | 3/13/2025 | | Reiterated Rating | $28.00 ➝ $28.00 | Buy | 00.00% | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/13/2025 |
CRVO CervoMed | $8.85 -3.8% | 3/13/2025 | | Upgrade | $14.00 ➝ $14.00 | Neutral ➝ Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 3/13/2025 |
TNYA Tenaya Therapeutics | $1.20 -6.3% | 3/12/2025 | | Lower Price Target | $18.00 ➝ $9.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/12/2025 |
SLDB Solid Biosciences | $5.39 +1.5% | 3/7/2025 | | Reiterated Rating | $16.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 3/7/2025 |
EYPT Eyepoint Pharmaceuticals | $13.35 +0.2% | 3/6/2025 | | Reiterated Rating | $33.00 ➝ $33.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 3/6/2025 |
OCGN Ocugen | $1.07
| 3/6/2025 | | Boost Price Target | $6.00 ➝ $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/6/2025 |
PASG Passage Bio | $7.00 +0.4% | 3/4/2025 | | Lower Price Target | $140.00 ➝ $120.00 | Buy | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 3/4/2025 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 3/4/2025 | | Lower Price Target | $30.00 ➝ $28.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 3/4/2025 |
PRME Prime Medicine | $4.07 -0.2% | 3/3/2025 | | Reiterated Rating | $15.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 3/3/2025 |
IOVA Iovance Biotherapeutics | $2.27 -6.2% | 3/3/2025 | | Lower Price Target | $34.00 ➝ $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 3/3/2025 |
NTLA Intellia Therapeutics | $11.42
| 2/28/2025 | | Lower Price Target | $91.00 ➝ $68.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/28/2025 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 2/28/2025 | | Lower Price Target | $62.00 ➝ $54.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/28/2025 |
DYN Dyne Therapeutics | $13.15 -0.2% | 2/28/2025 | | Reiterated Rating | $50.00 ➝ $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 2/28/2025 |
RNA Avidity Biosciences | $44.74 +9.0% | 2/28/2025 | | Reiterated Rating | $65.00 ➝ $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/28/2025 |
|
CGTX Cognition Therapeutics | $2.17 -8.1% | 2/26/2025 | | Reiterated Rating | $11.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 2/26/2025 |
TSHA Taysha Gene Therapies | $3.07 -5.2% | 2/26/2025 | | Reiterated Rating | $7.00 ➝ $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 2/26/2025 |
ALNY Alnylam Pharmaceuticals | $465.89 -0.6% | 2/26/2025 | | Reiterated Rating | $300.00 ➝ $300.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/26/2025 |
MGTX MeiraGTx | $7.61 -0.8% | 2/24/2025 | | Reiterated Rating | $36.00 ➝ $36.00 | Buy | 00.00% | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 2/24/2025 |
PRTA Prothena | $8.21 -2.6% | 2/21/2025 | | Reiterated Rating | $40.00 ➝ $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 2/21/2025 |
KRYS Krystal Biotech | $143.68 -0.5% | 2/20/2025 | | Boost Price Target | $212.00 ➝ $218.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 2/20/2025 |
SLDB Solid Biosciences | $5.39 +1.5% | 2/19/2025 | | Boost Price Target | $15.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 2/19/2025 |
STOK Stoke Therapeutics | $23.46 -1.8% | 2/19/2025 | | Reiterated Rating | $24.00 ➝ $24.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 2/19/2025 |
OTLK Oncobiologics | $1.04 -4.6% | 2/18/2025 | | Reiterated Rating | $3.00 ➝ $3.00 | Neutral | 00.00% | View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 2/18/2025 |
OCGN Ocugen | $1.07
| 2/13/2025 | | Reiterated Rating | $6.00 ➝ $6.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 2/13/2025 |
CRSP CRISPR Therapeutics | $56.26 +0.7% | 2/13/2025 | | Lower Price Target | $94.00 ➝ $84.00 | Buy | 00.00% | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/13/2025 |
ARWR Arrowhead Pharmaceuticals | $29.72
| 2/11/2025 | | Reiterated Rating | $60.00 ➝ $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/11/2025 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 2/11/2025 | | Lower Price Target | $39.00 ➝ $30.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 2/11/2025 |
COYA Coya Therapeutics | $6.05 -2.6% | 2/6/2025 | | Reiterated Rating | $14.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025 |
EYPT Eyepoint Pharmaceuticals | $13.35 +0.2% | 2/6/2025 | | Reiterated Rating | $33.00 ➝ $33.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 2/6/2025 |
CRGX CARGO Therapeutics | $4.47
| 1/30/2025 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 1/30/2025 |
SABS SAB Biotherapeutics | $2.12
| 1/29/2025 | | Reiterated Rating | $25.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 1/29/2025 |
OCGN Ocugen | $1.07
| 1/23/2025 | | Reiterated Rating | $6.00 ➝ $6.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 1/23/2025 |
DYN Dyne Therapeutics | $13.15 -0.2% | 1/10/2025 | | Reiterated Rating | $50.00 ➝ $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 1/10/2025 |
IMRX Immuneering | $8.49 +3.4% | 1/8/2025 | | Reiterated Rating | $13.00 ➝ $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 1/8/2025 |
OCS Oculis | $17.40 +1.0% | 1/7/2025 | | Reiterated Rating | $28.00 ➝ $28.00 | Buy | 00.00% | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 1/7/2025 |
SONN Sonnet BioTherapeutics | $5.90 +49.0% | 12/20/2024 | | Lower Price Target | $30.00 ➝ $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Sonnet BioTherapeutics (NASDAQ:SONN) on 12/20/2024 |
STOK Stoke Therapeutics | $23.46 -1.8% | 12/20/2024 | | Initiated Coverage | $24.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 12/20/2024 |
PRTA Prothena | $8.21 -2.6% | 12/20/2024 | | Initiated Coverage | $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 12/20/2024 |
MNMD Mind Medicine (MindMed) | $9.44 -2.2% | 12/20/2024 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 12/20/2024 |
CGTX Cognition Therapeutics | $2.17 -8.1% | 12/19/2024 | | Reiterated Rating | $11.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 12/19/2024 |
KRYS Krystal Biotech | $143.68 -0.5% | 12/18/2024 | | Reiterated Rating | $212.00 ➝ $212.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 12/18/2024 |
TNYA Tenaya Therapeutics | $1.20 -6.3% | 12/18/2024 | | Reiterated Rating | $18.00 ➝ $18.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 12/18/2024 |
INOD Innodata | $62.56 +2.6% | 12/13/2024 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for Chardan Capital rating of Innodata (NASDAQ:INOD) on 12/13/2024 |
EDIT Editas Medicine | $2.69 -0.7% | 12/13/2024 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 12/13/2024 |
KRYS Krystal Biotech | $143.68 -0.5% | 12/12/2024 | | Reiterated Rating | $212.00 ➝ $212.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 12/12/2024 |
ARWR Arrowhead Pharmaceuticals | $29.72
| 12/12/2024 | | Reiterated Rating | $60.00 ➝ $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/12/2024 |
PRQR ProQR Therapeutics | $2.19
| 12/12/2024 | | Reiterated Rating | $4.00 ➝ $4.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 12/12/2024 |
CRVO CervoMed | $8.85 -3.8% | 12/11/2024 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 12/11/2024 |
SLN Silence Therapeutics | $4.51 -7.6% | 12/10/2024 | | Reiterated Rating | $55.00 ➝ $55.00 | Buy | 00.00% | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 12/10/2024 |
CRSP CRISPR Therapeutics | $56.26 +0.7% | 12/10/2024 | | Reiterated Rating | $94.00 ➝ $94.00 | Buy | 00.00% | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 12/10/2024 |
FBRX Forte Biosciences | $10.56 +1.0% | 12/4/2024 | | Reiterated Rating | $64.00 ➝ $64.00 | Buy | 00.00% | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 12/4/2024 |
SNTI Senti Biosciences | $1.35 -2.2% | 12/2/2024 | | Reiterated Rating | $10.00 ➝ $10.00 | Buy | 00.00% | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 12/2/2024 |
OTLK Oncobiologics | $1.04 -4.6% | 12/2/2024 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 12/2/2024 |
ARWR Arrowhead Pharmaceuticals | $29.72
| 11/27/2024 | | Reiterated Rating | $60.00 ➝ $60.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 11/27/2024 |
MGX Metagenomi | $1.86 -1.6% | 11/20/2024 | | Reiterated Rating | $15.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 11/20/2024 |
IMRX Immuneering | $8.49 +3.4% | 11/20/2024 | | Reiterated Rating | $13.00 ➝ $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 11/20/2024 |
RGNX REGENXBIO | $9.20 -3.1% | 11/20/2024 | | Reiterated Rating | $52.00 ➝ $52.00 | Buy | 00.00% | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 11/20/2024 |
ABUS Arbutus Biopharma | $4.46 -9.0% | 11/20/2024 | | Reiterated Rating | $4.50 ➝ $5.00 | Buy | 00.00% | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/20/2024 |
RCKT Rocket Pharmaceuticals | $3.16 -3.7% | 11/18/2024 | | Reiterated Rating | $62.00 ➝ $62.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/18/2024 |
OCGN Ocugen | $1.07
| 11/18/2024 | | Reiterated Rating | $6.00 ➝ $6.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 11/18/2024 |
MGTX MeiraGTx | $7.61 -0.8% | 11/18/2024 | | Reiterated Rating | $36.00 ➝ $36.00 | Buy | 00.00% | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 11/18/2024 |
NTLA Intellia Therapeutics | $11.42
| 11/18/2024 | | Boost Price Target | $88.00 ➝ $91.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
FBRX Forte Biosciences | $10.56 +1.0% | 11/15/2024 | | Boost Price Target | $3.00 ➝ $64.00 | Buy | 00.00% | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 11/15/2024 |
CGTX Cognition Therapeutics | $2.17 -8.1% | 11/15/2024 | | Reiterated Rating | $11.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/15/2024 |
CLSD Clearside Biomedical | $0.32 -8.6% | 11/15/2024 | | Reiterated Rating | $90.00 ➝ $90.00 | Buy | 00.00% | View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 11/15/2024 |
CRVO CervoMed | $8.85 -3.8% | 11/14/2024 | | Reiterated Rating | $55.00 ➝ $55.00 | Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 11/14/2024 |
TSHA Taysha Gene Therapies | $3.07 -5.2% | 11/14/2024 | | Reiterated Rating | $7.00 ➝ $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/14/2024 |
PASG Passage Bio | $7.00 +0.4% | 11/14/2024 | | Reiterated Rating | $140.00 ➝ $140.00 | Buy | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 11/14/2024 |
FDMT 4D Molecular Therapeutics | $6.81 -3.7% | 11/14/2024 | | Reiterated Rating | $39.00 ➝ $39.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 11/14/2024 |
SLN Silence Therapeutics | $4.51 -7.6% | 11/14/2024 | | Reiterated Rating | $55.00 ➝ $55.00 | Buy | 00.00% | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 11/14/2024 |
ALUR Allurion Technologies | $2.17 -1.1% | 11/14/2024 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 11/14/2024 |
MCRB Seres Therapeutics | $15.91 -9.4% | 11/13/2024 | | Reiterated Rating | $25.00 ➝ $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 11/13/2024 |
RNA Avidity Biosciences | $44.74 +9.0% | 11/13/2024 | | Reiterated Rating | $65.00 ➝ $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 11/13/2024 |
DYN Dyne Therapeutics | $13.15 -0.2% | 11/13/2024 | | Reiterated Rating | $50.00 ➝ $50.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 11/13/2024 |